Carrier Screening Market

Future Market Insights

Key Insight

The carrier screening market is projected to grow from USD 1,697.2 million in 2025 to USD 5,462.6 million by 2035, at a CAGR of 12.4%. Expanded Carrier Screening will dominate with a 54.7% market share, while cystic fibrosis will lead the medical condition segment with a 38.6% share.

September 03, 2025

Anurag Sharma

234 Pages

Cite this Report

Carrier Screening Market

https://www.futuremarketinsights.com/reports/carrier-screening-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Autogenomics Inc
T. Rowe Price
Eurofins Scientific
F. Hoffmann-La Roche Ag
Fulgent Genetics Inc
Illumina
Invitae Corporation
Luminex Corporation
OPKO Health
Quest Diagnostics
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Carrier Screening Market

Key Players

Similar Industry Reports